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ABSTRACT
There comes a time when the understanding of the cutaneous healing process becomes essential due to the need for
a precocious tissue repair to reduce the physical, social, and psychological morbidity. Advances in the knowledge on
the control of interaction among cells, matrix and growth factors will provide more information on the Regenerative
Medicine, an emerging area of research in medical bioengineering. However, considering the dynamism and complexity
of the cutaneous healing response, it is fundamental to understand the control mechanism exerted by the interaction
and synergism of both systems, cutaneous nervous and central nervous, via hypothalamus hypophysis-adrenal axis,
a relevant subject, but hardly ever explored. The present study reviews the neuro-immune-endocrine physiology of
the skin responsible for its multiple functions and the extreme disturbances of the healing process, like the excess and
deficiency of the extracellular matrix deposition.
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Plastic surgery, a field that is advancing at a rapid pace,
is becoming multi- and interdisciplinary by the integra-
tion with other medical-surgical specialties, thereby as-
suring a better care for patients. Due to unquestion-
able advances, plastic surgery no longer deals only with
the correction of congenital and acquired deformities of
tissues and organs, but also seeks functional, cosmetic
and psychological results in a more holistic manner
(Ferreira 2004).
PHYSIOLOGY OF THE SKIN SCARRING RESPONSE
The skin has an autonomous “Cutaneous Nervous Sys-
tem” (CTNS), or neurosensory system, which is the
main responsible for the scarring process, sympathetic
stimulus in neurogenic inflammation, and generation of
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bioelectric currents (Toyoda et al. 1999, Gragnani et al.
2007a). This system consists of sensory cells, melano-
cytes, and keratinocytes, all of which release neuro-
peptides, and of immune and endothelial cells. Its func-
tioning process is similar to the central nervous com-
mand of the “Hypothalamus-Hypophysis-Adrenal axis”
(HHAA) (Lotti et al. 1995, Zouboulis et al. 2002,
Ziegler et al. 2007).
When the skin is subjected to environmental stres-
ses, stimuli are transmitted to the “Central Nervous Sys-
tem” (CNS) by afferent peripheral neural signaling.
In this situation, the sebaceous glands release cortico-
tropin-releasing hormone (CRH), similar to that released
by the hypothalamus (Slominski et al. 2006a, b, Krause
et al. 2007). This hormone, through an endocrine path-
way, combines with the hypothalamic CRH and, by act-
ing on the hypophysis, stimulates the “Sympathetic
Nervous System” (SNS), consequently increasing the
release of proopiomelanocortin (POMC)-derived pep-
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tides, represented by the adrenocorticotrophic hormone
(ACTH), melanocyte-stimulating hormone (MSH), and
prolactin, a group also known as “stress hormones”
(Grützkau et al. 2000, Kono et al. 2001, Slominski et
al. 2004).
When an organism is subjected to stress, certain
parts of the brain synergistically activate the SNS by
stimulating the HHAA (Dhabhar and McEwen 1999).
The stress response is transmitted to the organs, and es-
pecially to the skin, by the integration with the CNS,
through the stimulation of sympathetic nerve fibers that
release neurotransmitters and neuropeptides (Slominski
and Wortsman 2000, Toyoda et al. 2002).
On the other hand, the activation of the HHAA,
via CNS, stimulates the basal layer of sebaceous glands
to produce CRH, which in turn provides feedback that
stimulates this axis, establishing an equivalence and
functional synergism between the HHAA and CTNS
(Zouboulis et al. 2002, Krause et al. 2007, Kono et
al. 2001, Toyoda et al. 2002, Gauthier 1996, Toyoda
and Morohashi 2001). Therefore, the response to stress
stimuli from one axis may exacerbate the sympathetic
function of the other.
The triggering of the scarring process depends
on the directional migration (electrotaxis) of the cells,
which is caused by a wound current and the release of
neuropeptides by A-delta and C sensory nerve fibers
(Weiss et al. 1990, Schmelz and Petersen 2001, Slomin-
ski et al. 1993). These events correspond to the phase
of neurogenic inflammation, which will affect the sub-
sequent stages of the scarring process. Hence, electrical,
immunological, inflammatory and hormonal responses
of the scarring process are neurally modulated (Slomin-
ski et al. 1993, Kim et al. 1998). The relationship be-
tween cutaneous scarring and peripheral innervation is
evidenced by the delay in the healing after sympathec-
tomy (Glaser et al. 1999, Esteves Jr. et al. 2004).
Nerve fibers in synergy with the HHAA and CTNS
axes participate in the phase of neurogenic inflamma-
tion, allowing psychological influences interrelated to
the SNS to interfere with the cutaneous scarring process
(Allen et al. 1973). Therefore, in stress situations, sym-
pathetic hyperstimulation leads to hyperactivity of the
sweat glands and pilosebaceous units, modifying bio-
electrical and neurosecretory properties of the skin, and
causing imbalance in the scarring process (Pintér et al.
1997, Zancanaro et al. 1999, Sauerstein et al. 2000,
Kimyai-Asadi and Usman 2001, Storm et al. 2002).
A neural imbalance of the scarring process may
cause two types of pathological scarring. The first type
is characterized by an increase in nerve fibers, pro-in-
flammatory neuropeptides, and extracellular matrix, cor-
responding to the fibroproliferative scars (Parkhouse et
al. 1992, Crowe et al. 1994, Hochman et al. 2008b).
The second type is characterized by a decrease in these
parameters, and is represented by burn wounds (Altun
et al. 2001).
EXCESS OF EXTRACELLULAR MATRIX:
FIBROPROLIFERATIVE SCARS
Although scarring is usually a beneficial process for
the organism, an excessive deposition of some proteins,
such as collagen, may cause cosmetic and functional
complications, resulting in keloid and hypertrophic
scars. Nowadays, hypertrophic scars are considered
phenotypic expressions of keloids of lesser intensity
(Muir 1990, Placik and Lewis 1992) and, as a group,
they are known as fibroproliferative scars (Tredget et
al. 1997, Bock and Mrowietz 2002, Rahban and Garner
2003, Hochman and Ferreira 2007). Keloid is a disorder
more common in tropical countries. It shows a preva-
lence of 1.5% in the US. In Africa, its incidence reaches
16% (Bock and Mrowietz 2002). Keloid is frequent
in Brazil (although there are no statistical data on this
subject) probably due to the tropical climate and intense
miscegenation of the population (Canary et al. 1990).
Fibroproliferative scars, regardless of their size,
have an important aesthetic, social and psychological
impact in patients, since they usually occur in more
exposed areas (Bock et al. 2006, Clayman et al. 2006,
Rusciani et al. 2006). Pain, pruritus, ulcerations and
loss of functional capacity add up to the disturbance
caused by the deformity when it is located in articular
regions (Komarcevic et al. 2000, Bock and Mrowietz
2002, Davies et al. 2004). These symptoms negatively
affect factors associated with mental health, such as
sleepiness, body image, self-esteem, sexual function-
ing, and self-confidence, interfering in social function-
ing and life (Teich Alasia et al. 1996, Bock et al. 2006).
Moreover, the lack of efficient preventive measures
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results in elevated medical costs (Davies et al. 2004,
Bickers et al. 2006).
Burn patients have a prevalence of hypertrophic
scars of about 67%, which leads to high medical costs
due to the size of the wound surface area (Bombaro et al.
2003). In Brazil, the highest prevalence of burn injury
(61.4%) is found in individuals up to 20 years of age,
and reaches 23% in the economically active age group
(adults between 20 to 39 years of age). According to
these data, the age group that is most at risk of burn
injury is coincident with that most at risk of fibropro-
liferative scars. Therefore, in Brazil, both burn injuries
and fibroproliferative scars represent a public health
problem (Rossi et al. 1998).
In the field of surgery, problems with fibroprolif-
erative scars are not only restricted to plastic surgery.
In thoracic surgery, fibroproliferative scars are a com-
mon complication. This occurs because the thoracic
wall is at high risk for this type of lesion, and also
due to the increasing number of surgical myocardial
revascularizations (Manuskiatti and Fitzpatrick 2002).
Fibroproliferative scars are common in obstetrics and
gynecology, resulting from breast surgeries and cesa-
rean sections (Ishizuka et al. 2007).
The mechanism of scar formation is still not com-
pletely understood. Consequently, treatments are pal-
liative, and there are no efficient preventive measures
(Keira et al. 2004, Campaner et al. 2006, Hochman et
al. 2008b). In the case of keloids, the maximum ex-
pression of fibroproliferative scars, the difficulty in un-
derstanding their pathogenesis comes from the fact
that this condition occurs exclusively in humans (Placik
and Lewis 1992, O’Sullivan et al. 1996, Hochman et
al. 2004, 2005). Despite this difficulty, there is a con-
sensus that keloid is a benign neoplasia, because it de-
velops in vitro even in the absence of humoral factors
(Placik and Lewis 1992, Keira et al. 2004, Hochman
et al. 2008a).
It is estimated that 75% of all dermatopathies are
caused by psychophysiological disturbances, because
the skin reacts directly to psychoemotional stimuli. The
study of the relationship between mind and skin has
had a very fast development in the last decades, con-
solidating the field of science known as psychoderma-
tology (Koo and Lebwohl 2001, Jafferany 2007).
Keloid and hypertrophic scars may also represent
somatic manifestations of psychological origin (Barros
and Barros 1996). However, despite the interrelation
of psychoneurogenic mechanisms with fibroprolifera-
tive scars (Liang et al. 2004, Hochman et al. 2008b),
these pathological scars still have not been addressed
and sufficiently studied as a psychophysiological dis-
turbance.
DEFICIENCY OF EXTRACELLULAR MATRIX:
BURN WOUNDS/SKIN BIOENGINEERING
The development of skin bioengineering is a con-
sequence of the need for permanent wound closure
in patients with skin loss. In this type of injury, the
wound must be promptly closed to prevent fluid and
protein loss, and bacterial invasion (Leigh et al. 1994).
Synthetic and biological skin substitutes can be used
either for permanent or temporary wound closure.
Human cadaver skin allograft is the material most com-
monly used for temporary wound closure. On the other
hand, autologous cultured keratinocytes are used for
permanent wound closure (Morgan and Yarmush 1997,
Gragnani et al. 2002).
Keratinocytes are responsible for the skin resist-
ance to physical and chemical insults, and skin perme-
ability to the water (Tompkins and Burke 1996). More-
over, keratinocyte growth factor (KGF) mediates the
important mitotic activity during the wound healing
process (Finch et al. 1995). Keratinocytes also repre-
sent an important source of neural growth factor (NGF),
which regulates the scarring process by the production
and release of sympathetic pro-inflammatory neuropep-
tides through cutaneous nerve terminals (Niessen et
al. 2001).
Keratinocytes subpopulations (stem cells, transit
amplifying (TA) cells, and terminally differentiated
cells) that are present in the epidermis are capable of
self-regeneration and differentiation (Gragnani et al.
2004, 2008, Youn 2004). A fragment of 1 cm2 obtained
from normal skin may be expanded more than 5000
times within 3 to 4 weeks, producing enough epithelium
to cover the total body surface area of an adult (Gragnani
et al. 2004, 2007a, b). In this way, the neo-epithelium
provides at the same time skin closure and neural sub-
strates that control homeostasis during wound healing.
An Acad Bras Cienc (2009) 81 (3)
“main” — 2009/7/27 — 15:57 — page 626 — #4
626 LYDIA M. FERREIRA, ALFREDO GRAGNANI, FABIANNE FURTADO and BERNARDO HOCHMAN
Studies on the behavior of keratinocytes in re-
sponse to hypoxia, to the lack of glucose, or to both
factors, as well as studies on apoptosis and cellular
death under different types of insults, and on the use
of different substances for the treatment of these delete-
rious conditions (e.g., antioxidant supplementation) are
very important because they enable us to anticipate and
prevent problems caused by age, systemic diseases, and
local wound conditions at the time of their clinical use
(Duarte et al. 2004).
Therefore, research on skin bioengineering is of
prime importance for the ideal combination of bioma-
terials, cultured cells and growth factors in the produc-
tion of permanent wound closure materials, resulting in
an increase in the survival of patients, for instance, with
extensive burn wounds (Gragnani et al. 2002, Sobral et
al. 2007a, b).
The fundamental advantage of skin substitutes is
the possibility of their use as a permanent wound clo-
sure, enabling the control of the scarring response by
producing larger amounts of a new growth factor, pro-
tein or hormone, thereby interfering with the healing
process, congenital diseases of the skin, and systemic
diseases, such as inhibition of the expression of TGF-
β1 (Campaner et al. 2006, Ramos et al. 2008).
RESUMO
Aproxima-se uma época na qual é fundamental a compreen-
são do processo cicatricial cutâneo frente à necessidade da
restauração tecidual precoce, visando a diminuição das mor-
bidades física, social e psicológica. O avanço no conhecimento
acerca do controle das interações entre as células, a matriz
e os fatores de crescimento dará maiores informações à Medi-
cina Regenerativa, área de pesquisa emergente da bioenge-
nharia médica. Entretanto, diante do dinamismo e complexi-
dade da resposta cicatricial cutânea torna-se indispensável
o entendimento do mecanismo de controle exercido pela in-
teração e sinergismo do sistema nervoso cutâneo e o sistema
nervoso central, via eixo hipotálamo-hipófise-adrenal, tema
relevante, porém, pouco abordado. O presente estudo revisa
a fisiologia neuro-imuno-endócrina da pele, responsável por
suas múltiplas funções, e os distúrbios extremos do processo
cicatricial, como o excesso e deficiência de deposição da ma-
triz extracelular.
Palavras-chave: cicatrização de feridas, queratinócitos, fi-
broblastos, engenharia tissular, pele, cirurgia plástica.
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